| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $35,166,341 ) (Continued on the next page) |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK128247 | The Regulation of Hepatic Metabolic Zonation by the Diabetes Gene TCF7L2 | 000 | 3 | NIH | 12/18/2023 | $440,457 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA262757 | Enhancing endoplasmic reticulum stress in ovarian cancer | 001 | 3 | NIH | 4/17/2024 | $31,777 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA262757 | Enhancing endoplasmic reticulum stress in ovarian cancer | 000 | 3 | NIH | 3/19/2024 | $251,756 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA262041 | Consumer-based meditation app, Calm, for treatment of sleep disturbance in hematological cancer patients | 000 | 4 | NIH | 4/12/2024 | $324,702 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DE031477 | Functional peripheral and central vagal neural circuits of interoception inhibiting pain | 000 | 3 | NIH | 11/30/2023 | $652,130 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI161363 | Mechanism-based targeting of the RNA processing machinery of SARS-CoV-2- | 000 | 3 | NIH | 2/22/2024 | $172,636 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA257391 | PAI-1-mediated early-onset endometrial cancer | 000 | 4 | NIH | 4/9/2024 | $424,546 |
| 2024 | 2024 | UNI OF TX HEALTH SCIENCE CTR SAN ANT | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01GM141091 | Genome Maintenance via the BRCA-RAD54 Axis | 000 | 4 | NIH | 2/13/2024 | $292,950 |
| 2024 | 2024 | UNI OF TX HEALTH SCIENCE CTR SAN ANT | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01GM141091 | Genome Maintenance via the BRCA-RAD54 Axis | 001 | 4 | NIH | 2/14/2024 | $22,116 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | K23HD101701 | Genomic determinants of bronchopulmonary dysplasia development in humans and an animal model | 000 | 4 | NIH | 3/22/2024 | $163,080 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA246807 | Radiation-induced senescence in the brain microenvironment: Implications for glioblastoma recurrence and therapy | 001 | 4 | NIH | 4/17/2024 | $17,834 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA246807 | Radiation-induced senescence in the brain microenvironment: Implications for glioblastoma recurrence and therapy | 000 | 4 | NIH | 2/29/2024 | $320,992 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA257148 | Lineage Plasticity, due to Disruption of MnSOD Biology, drives resistance to Ionizing Radiation / Androgen Deprivation Therapy | 001 | 4 | NIH | 4/17/2024 | $19,190 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA257148 | Lineage Plasticity, due to Disruption of MnSOD Biology, drives resistance to Ionizing Radiation / Androgen Deprivation Therapy | 000 | 4 | NIH | 2/22/2024 | $345,411 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HL153403 | TCF7L2 Insoforms in Canonical Wnt Signaling During Cardiac Hpertrophy & Failure | 000 | 5 | NIH | 3/21/2024 | $442,707 |
| 2024 | 2024 | UNI OF TX HEALTH SCIENCE CTR SAN ANT | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01ES031063 | Study of Cleaners in San Antonio: Immunologic and Inflammatory Responses to Total Volatile Organic Compound (VOC) Exposure | 001 | 4 | NIH | 2/14/2024 | $528,191 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AA031407 | Deciphering RNA Splicing Control of Lipid Metabolism and Alcoholic Liver Injury | 000 | 1 | NIH | 2/29/2024 | $504,482 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R13CA287954 | Advancing the Science of Cancer in Latinos 2024 | 000 | 1 | NIH | 2/20/2024 | $10,000 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01NS131652 | CB1 receptors mediate metaplasticity in the cerebellar circuit | 000 | 1 | NIH | 2/29/2024 | $407,189 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI177345 | Lymphoid residency of Tcf-1+ CD8+ T cells during tumor vaccine responses | 000 | 1 | NIH | 2/5/2024 | $397,441 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U01CA283749 | The role of tumor-macrophage hybrid cells in prostate cancer metastasis | 000 | 1 | NIH | 4/22/2024 | $637,168 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21CA289167 | Activation of Drug and Biologic Conjugates by Click Chemistry and their Tumor-selective Targeting for Prostate Cancer Suppression | 000 | 1 | NIH | 3/5/2024 | $191,675 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21CA286307 | Development of Caspase Cleavage Targeting Chimeras (CACTACs) for Targeted Protein Cleavage | 000 | 1 | NIH | 11/29/2023 | $192,844 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21ES035997 | Understanding post translational modifiers in DNA damage repair | 000 | 1 | NIH | 3/21/2024 | $232,500 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA279681 | Function of the METTL3-NUP93 complex-mediated nuclear export of m6A-modified mRNAs in castration-resistant prostate cancer. | 000 | 1 | NIH | 11/27/2023 | $439,997 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HS029891 | Evaluation of Post-Acute Care Access and Outcomes: Influence of Social Determinants of Health on Urban and Rural Rehabilitation Service Areas Before and After COVID-19 | 000 | 1 | AHRQ | 2/26/2024 | $394,886 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U01AI182210 | An oral vaccine against Chlamydia trachomatis | 000 | 1 | NIH | 4/18/2024 | $2,202,675 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG061729 | Sulfatide deficiency: A novel mechanism leading to reactive astrogliosis in aging and Alzheimer?s disease | 000 | 2 | NIH | 3/7/2024 | $564,248 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21CA277399 | Development of a new class of EZH2 inhibitors in ERa-negative breast cancer. | 000 | 1 | NIH | 12/20/2023 | $213,194 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30MH134482 | Identifying a critical developmental period for cognitive speed in a mouse model for neurodevelopmental disorders | 001 | 1 | NIH | 3/11/2024 | $0 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30MH134482 | Identifying a critical developmental period for cognitive speed in a mouse model for neurodevelopmental disorders | 000 | 1 | NIH | 3/11/2024 | $40,231 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30AI176699 | Macrophage NR4A nuclear receptors in tuberculosis pathogenesis | 001 | 1 | NIH | 2/1/2024 | $0 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30AI176699 | Macrophage NR4A nuclear receptors in tuberculosis pathogenesis | 000 | 1 | NIH | 12/20/2023 | $37,034 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R35GM153228 | Mechanisms of enhancer dynamics and assembly in gene regulation | 000 | 1 | NIH | 3/11/2024 | $387,508 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21CA277164 | Targeting the RNA modifying enzyme ALKBH5 in Medulloblastoma | 000 | 2 | NIH | 4/23/2024 | $172,098 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HD108124 | The genome integrity and epigenome of sperm from men with recurrent pregnancy loss | 000 | 2 | NIH | 3/15/2024 | $576,629 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01NS132778 | Interrogating the role of LRP1 subdomains in neural stem cell function | 001 | 1 | NIH | 1/13/2024 | $46,538 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA279667 | Validation, Calibration, and Translation of Restriction Spectrum Imaging Signal Maps to enhance MRI diagnostic capabilities in Prostate Cancer | 001 | 2 | NIH | 4/18/2024 | $28,698 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA279667 | Validation, Calibration, and Translation of Restriction Spectrum Imaging Signal Maps to enhance MRI diagnostic capabilities in Prostate Cancer | 000 | 2 | NIH | 3/26/2024 | $516,598 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG081422 | Cardiolipin Remodeling in Alzheimer?s Disease | 000 | 2 | NIH | 4/17/2024 | $339,063 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA277498 | Novel approach of targeting AT-rich S/MAR regions for treating therapy resistant breast cancers | 000 | 2 | NIH | 4/16/2024 | $459,961 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG082360 | The San Antonio Heart and Mind Study | 000 | 2 | NIH | 3/13/2024 | $3,220,614 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK133463 | Cellular mechanisms of NLRP3 activation by ALCAT1 in diet-induced obesity | 000 | 2 | NIH | 2/23/2024 | $475,723 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AI172157 | Negative allosteric modulators for bradykinin B1 receptors | 000 | 2 | NIH | 1/5/2024 | $174,375 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01NS128574 | Chronic Intermittent Hypoxia and Hyperalgesic Priming | 000 | 2 | NIH | 3/8/2024 | $560,256 |
| 2024 | 2024 | UNI OF TX HEALTH SCIENCE CTR SAN ANT | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R03HD111405 | Chromosome 18 Cohort Phenotype Enrichment to Strengthen the Gabriella Miller Kids First Program | 000 | 2 | NIH | 2/14/2024 | $139,500 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AG081709 | The role of medullary thymic epithelial cell-derived growth factors in regulating thymus growth and atrophy | 000 | 2 | NIH | 12/1/2023 | $174,375 |
| 2024 | 2024 | UNI OF TX HEALTH SCIENCE CTR SAN ANT | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R61AT012117 | Development of a phenotypic screening assay for novel compounds that inhibit peripheral pain-sensing neurons | 000 | 2 | NIH | 1/29/2024 | $380,522 |
| 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F31DA057832 | Reversal of ventilatory depression by drug mixtures | 000 | 2 | NIH | 1/5/2024 | $37,008 |
|